ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,345Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1448

$1.51M Total Retail Price of All Prescriptions

Rank: 14 out of 1448

325 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 325 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 13,589 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

59% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$105 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LOVAZA 520 476 1 39
LIDODERM 366 350 2 81
AMLODIPINE BESYLATE 364 363 3 2
DIOVAN 334 325 4 15
CLOPIDOGREL 326 307 5 10
ATORVASTATIN CALCIUM 270 254 6 4
CRESTOR 263 238 7 17
PREDNISONE 261 253 8 110
PLAVIX 196 192 9 14
LEVOFLOXACIN 179 173 10 131
VOLTAREN 173 168 11 107
ALENDRONATE SODIUM 167 166 12 41
AZITHROMYCIN 165 161 13 76
TRIAMCINOLONE ACETONIDE 162 160 14 96
PATADAY 159 154 15 207
AVODART 159 157 15 120
CARVEDILOL 150 149 17 1
CELEBREX 148 148 18 77
NEXIUM 147 146 19 49
ACTONEL 136 136 20 117
SINGULAIR 134 120 21 91
JANUVIA 132 131 22 64
BYSTOLIC 132 117 22 32
FLUOCINONIDE 132 124 22 144
ZOLPIDEM TARTRATE 126 121 25 34
ISOSORBIDE MONONITRATE ER 124 124 26 16
LOSARTAN POTASSIUM 124 124 26 11
SIMVASTATIN 121 115 28 3
NIASPAN 120 107 29 47
IBANDRONATE SODIUM 116 116 30 148
TRILIPIX 115 106 31 86
ATELVIA 114 107 32 157
DIOVAN HCT 112 105 33 29
EVISTA 112 108 33 134
BENICAR 109 109 35 50
OMEPRAZOLE 106 105 36 23
LYRICA 104 99 37 159
ATENOLOL 104 103 37 12
MONTELUKAST SODIUM 103 94 39 135
CLOBETASOL PROPIONATE 101 97 40 250
NASONEX 99 89 41 155
TAMSULOSIN HCL 95 95 42 46
WELCHOL 94 86 43 103
LEVOTHYROXINE SODIUM 93 77 44 21
PANTOPRAZOLE SODIUM 89 88 45 42
AMOXICILLIN 87 87 46 142
METFORMIN HCL ER 87 80 46 191
AMMONIUM LACTATE 86 74 48 334
ADVAIR DISKUS 81 81 49 74
PENNSAID 80 76 50 340
PROCRIT 79 79 51 244
ALLOPURINOL 78 73 52 43
ACTOS 78 72 52 92
MELOXICAM 75 75 54 73
RAPAFLO 75 74 54 291
AMITIZA 74 63 56 189
PROCTOZONE-HC 72 70 57 307
METOPROLOL SUCCINATE 72 61 57 6
SYMBICORT 71 70 59 208
FLUTICASONE PROPIONATE 70 69 60 130
TAMIFLU 69 66 61 353
ZETIA 68 57 62 28
EXFORGE 68 68 62 80
NAMENDA 66 66 64 93
SPIRIVA 66 62 64 97
AGGRENOX 65 64 66 240
RANEXA 65 65 66 37
VESICARE 64 63 68 205
FUROSEMIDE 63 52 69 7
PRAVASTATIN SODIUM 63 61 69 20
LUNESTA 59 59 71 218
BARACLUDE 59 47 71 373
BENICAR HCT 58 52 73 84
RESTASIS 58 47 73 376
GLIPIZIDE 58 58 73 75
NAPHAZOLINE HCL 57 57 76 188
CIPROFLOXACIN HCL 55 54 77 137
ACETAMINOPHEN-CODEINE 55 51 S3 77 113
DALIRESP 53 41 79 234
ONGLYZA 52 46 80 180
ANTARA 52 44 80 277
CICLOPIROX 52 51 80 385
BONIVA 51 51 83 167
IBUPROFEN 51 46 83 85
DONEPEZIL HCL 51 51 83 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.